There were no significant differences in patient survival at 15 years ( 48 vs. 56 vs. 51 % , P = 0.14 ) , and 15-year graft survival ( censored for death ) in those patients in the CyAP group ( 47 vs. 44 vs. 59 % , P = 0.06 ) was not significantly different statistically .
